Cargando…
Heparin does not modify plasma daunomycin disappearance in acute leukaemia patients.
Autores principales: | Piazza, E., Cortellazzo, S., Ottolenghi, L., Poggi, A., Barbui, T., Donati, M. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1980
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010544/ https://www.ncbi.nlm.nih.gov/pubmed/7459213 |
Ejemplares similares
-
L-histidinol improves the selectivity and efficacy of alkylating agents and daunomycin in mice with P388 leukaemia.
por: Warrington, R. C., et al.
Publicado: (1989) -
Reduction of daunomycin toxicity by razoxane.
por: Wang, G., et al.
Publicado: (1981) -
Anticancer agents coupled to N-(2-hydroxypropyl)methacrylamide copolymers. II. Evaluation of daunomycin conjugates in vivo against L1210 leukaemia.
por: Duncan, R., et al.
Publicado: (1988) -
Topoisomerases inhibition and DNA binding mode of daunomycin–oligoarginine conjugate
por: Visone, Valeria, et al.
Publicado: (2020) -
Influence of the Drug Position on Bioactivity in Angiopep-2—Daunomycin Conjugates
por: Pethő, Lilla, et al.
Publicado: (2023)